Results 261 to 264 of about 2,033,302 (264)

Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease

Frontiers in Immunology
Naglaa Shoukry
exaly  

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis

International Journal of Molecular Sciences
Chen Huei Leo
exaly  

Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits

European Journal of Internal Medicine
Piero Portincasa, Agostino di Ciaula, Mohamad Khalil   +2 more
exaly  

Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease

American Journal of Physiology - Cell Physiology
Bruno Ramos-Molina, Mohammad Shafi Kuchay, Narendra Singh Choudhary   +2 more
exaly